Harvard Bioscience, Inc. (HBIO) Insider Trading Activity

NASDAQ$8.63-0.04 (-0.46%)
Market Cap
$39.47M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
233 of 849
Rank in Industry
13 of 42

HBIO Insider Trading Activity

HBIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$202,354
5
100
Sells
$0
0
0

Related Transactions

Snider Williamdirector
2
$103,604
0
$0
$103,604
DENELSKY STEPHEN Jdirector
1
$48,700
0
$0
$48,700
Duke John DChief Executive Officer
1
$25,050
0
$0
$25,050
Frost Mark TChief Financial Officer
1
$25,000
0
$0
$25,000

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including …

Insider Activity of Harvard Bioscience, Inc.

Over the last 12 months, insiders at Harvard Bioscience, Inc. have bought $202,354 and sold $0 worth of Harvard Bioscience, Inc. stock.

On average, over the past 5 years, insiders at Harvard Bioscience, Inc. have bought $253,418 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Snider William (director) — $103,604. DENELSKY STEPHEN J (director) — $48,700. Duke John D (Chief Executive Officer) — $25,050.

The last purchase of 8,475 shares for transaction amount of $41,104 was made by Snider William (director) on 2026‑03‑17.

List of Insider Buy and Sell Transactions, Harvard Bioscience, Inc.

2026-03-17PurchaseSnider Williamdirector
8,475
0.1887%
$4.85
$41,104
+30.90%
2026-03-17PurchaseDENELSKY STEPHEN Jdirector
10,000
0.2236%
$4.87
$48,700
+30.90%
2026-03-16PurchaseDuke John DChief Executive Officer
5,000
0.1118%
$5.01
$25,050
+27.15%
2026-03-16PurchaseSnider Williamdirector
12,525
0.279%
$4.99
$62,500
+27.15%
2026-03-16PurchaseFrost Mark TChief Financial Officer
5,000
0.1116%
$5.00
$25,000
+27.15%
2024-06-13PurchaseGreen James WChief Executive Officer
10,000
0.0242%
$2.91
$29,100
-25.95%
2024-06-06PurchaseGreen James WChief Executive Officer
20,000
0.0474%
$3.07
$61,400
-26.85%
2023-08-17PurchaseGreen James WChief Executive Officer
25,000
0.06%
$4.38
$109,500
-2.08%
2023-03-15PurchaseGreen James WChief Executive Officer
20,000
0.0468%
$2.60
$52,000
+71.21%
2023-03-15PurchaseEDRICK ALAN Idirector
16,192
0.0382%
$2.62
$42,423
+71.21%
2023-03-14PurchaseGreen James WChief Executive Officer
20,000
0.0475%
$2.67
$53,400
+69.29%
2023-03-14PurchaseEDRICK ALAN Idirector
13,808
0.0328%
$2.67
$36,867
+69.29%
2022-12-01PurchaseGreen James WChief Executive Officer
15,000
0.0341%
$2.61
$39,150
+54.15%
2022-11-30PurchaseGreen James WChief Executive Officer
15,000
0.0341%
$2.41
$36,150
+66.41%
2022-08-26PurchaseLOY BERTRAND
9,291
0.0231%
$3.41
$31,682
-5.78%
2022-08-24PurchaseLOY BERTRAND
8,244
0.0207%
$3.34
$27,535
-2.82%
2022-08-22PurchaseLOY BERTRAND
4,918
0.0118%
$3.16
$15,541
-2.21%
2022-08-18PurchaseLOY BERTRAND
1,151
0.0028%
$3.19
$3,672
-2.52%
2022-08-17PurchaseGreen James WChief Executive Officer
40,000
0.0961%
$3.19
$127,600
-2.82%
2022-06-15PurchaseGreen James WChief Executive Officer
30,000
0.0734%
$3.71
$111,300
-15.53%
Total: 300
*Gray background shows transactions not older than one year

Insider Historical Profitability

14.91%
Duke John DChief Executive Officer
105000
2.3065%
$910,350.0010
Snider Williamdirector
32000
0.7029%
$277,440.0020
DENELSKY STEPHEN Jdirector
21000
0.4613%
$182,070.0010
Frost Mark TChief Financial Officer
17500
0.3844%
$151,725.0010
Skystone Advisors LLC10 percent owner
3744819
82.2621%
$32.47M645
+9.98%
Green James WChief Executive Officer
3111091
68.3411%
$26.97M165
+16.62%
GRAZIANO CHANE10 percent owner
3105150
68.2106%
$26.92M50
+21.43%
HSO LIMITED PARTNERSHIP10 percent owner
2757257
60.5684%
$23.91M402
+8.24%
GREEN DAVIDdirector
925571
20.3319%
$8.02M1573
+46.83%
Duchemin JeffreyChief Executive Officer
830888
18.252%
$7.2M412
+3.29%
LEWIS EARL Rdirector
467350
10.2662%
$4.05M91
+28.78%
LOY BERTRAND
399651
8.7791%
$3.46M110
+3.36%
Gagnon Robert E.Chief Financial Officer
321169
7.0551%
$2.78M612
+16.32%
EDRICK ALAN Idirector
202485
4.448%
$1.76M30
+66.06%
KENNEDY JOHN Fdirector
177330
3.8954%
$1.54M20
<0.0001%
UVEGES GEORGEdirector
142685
3.1343%
$1.24M52
+13.66%
Eade Katherine A.director
121515
2.6693%
$1.05M10
+15.32%
Loewald Thomas Wdirector
103200
2.267%
$894,744.0010
+15.6%
*Gray background shows insiders who have made transactions during last year

HBIO Institutional Investors: Active Positions

Increased Positions35+55.56%9M+58.55%
Decreased Positions25-39.68%4M-24.87%
New Positions13New5MNew
Sold Out Positions8Sold Out3MSold Out
Total Postitions73+15.87%22M+33.68%

HBIO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Amh Equity Ltd$2,639.008.99%4.05M+538,832+15.36%2025-09-30
Harvey Partners, Llc$1,337.004.56%2.05M-91,099-4.25%2025-09-30
Vanguard Group Inc$1,207.004.12%1.85M-2,045-0.11%2025-09-30
Acadian Asset Management Llc$697.002.38%1.07M+30,465+2.93%2025-09-30
Meros Investment Management, Lp$599.002.04%918,259-1,686-0.18%2025-09-30
Renaissance Technologies Llc$566.001.93%868,478+76,500+9.66%2025-09-30
Blackrock, Inc.$405.001.38%621,367-493,208-44.25%2025-09-30
Granahan Investment Management, Llc$393.001.34%603,519-897,989-59.81%2025-09-30
Millennium Management Llc$373.001.27%571,703-68,164-10.65%2025-09-30
Dimensional Fund Advisors Lp$323.001.1%496,144-630,106-55.95%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.